For research use only. Not for therapeutic Use.
PF-04885614(CAT: I016683) stands as a significant compound in the field of pharmaceutical and pain research. Operating as a potent inhibitor of the sodium channel subtype NaV1.8, PF-04885614 offers promise in the modulation of pain signaling pathways. By targeting NaV1.8, which is predominantly expressed in sensory neurons and implicated in nociceptive transmission, this compound holds potential for pain management strategies. Its potency in inhibiting NaV1.8 underscores its relevance in designing novel analgesics and addressing conditions characterized by neuropathic or chronic pain.
| Catalog Number | I016683 |
| CAS Number | 1480833-70-2 |
| Molecular Formula | C₁₃H₁₄F₃N₃O |
| Purity | ≥95% |
| Target | Sodium Channel |
| Reference | [1]. Brady MAHER, et al. Treatment of Neurological and Neurodevelopmental Diseases and Disorders Associated with Aberrant Ion Channel Expression and Activity. US20180328915A1. |
